Actually, previous reports have shown that Ezrin and its binding protein NHERF1 were upregulated in response to estrogen in breast and ovarian cancers (Paradiso et al., 2013), implying that there might be a potential link between Ezrin and estrogen or ER. This evidence concerns the gene EZR and ovarian carcinoma.